Other Financial Information - Schedule of Other Financial Information (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Debt Disclosure [Abstract] | |||
| Total financing interest and debt costs | $ 1,392 | $ 773 | $ 617 |
| Less: Capitalized interest | 175 | 179 | 148 |
| Interest and debt expense | 1,217 | 594 | 469 |
| Research and development expenses | 427 | 353 | 320 |
| Excess of replacement cost over the carrying value of inventories (LIFO method) | 4,808 | 5,997 | 6,455 |
| LIFO profits (losses) on inventory drawdowns included in earnings | (38) | (111) | 14 |
| Foreign currency effects | (469) | 520 | (224) |
| Company’s share of equity affiliates foreign currency effects | $ (3) | $ 45 | $ (11) |
| X | ||||||||||
- Definition Company share of equity affiliates foreign currency effects. No definition available.
|
| X | ||||||||||
- Definition Foreign currency effects. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The effect of liquidating LIFO (last in first out) inventory layers on income. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The excess of replacement or current cost over the stated LIFO (last in first out) inventory value when the LIFO inventory method is utilized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of interest capitalized during the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Total interest costs incurred during the period and either capitalized or charged against earnings. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of the cost of borrowed funds accounted for as interest expense for debt. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|